However, no studies have investigated risk reduction and survival advantage in relation to contralateral prophylactic mastectomy for patients with a diagnosis of BC harboring ATM or CHEK2 likely pathogenic or pathogenic variants. The gene discussed is CHEK2; the disease is breast cancer.